SPY411.45-1.41 -0.34%
DIA337.53+0.74 0.22%
IXIC13,857.84-138.26 -0.99%

Akero Therapeutics Q4 EPS $(0.86) Down From $(0.55) YoY

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.86) per share. This is a 56.36 percent decrease over losses of $(0.55) per share from the same period last year.

· 03/16/2021 08:06
Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.86) per share. This is a 56.36 percent decrease over losses of $(0.55) per share from the same period last year.